These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2832097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain.
    Whalin ME, Strada SJ, Thompson WJ.
    Biochim Biophys Acta; 1988 Oct 28; 972(1):79-94. PubMed ID: 2846074
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb 28; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.
    Pyne NJ, Cooper ME, Houslay MD.
    Biochem J; 1986 Mar 01; 234(2):325-34. PubMed ID: 3013156
    [Abstract] [Full Text] [Related]

  • 8. Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium.
    Hambleton R, Krall J, Tikishvili E, Honeggar M, Ahmad F, Manganiello VC, Movsesian MA.
    J Biol Chem; 2005 Nov 25; 280(47):39168-74. PubMed ID: 16172121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle.
    Weishaar RE, Kobylarz-Singer DC, Kaplan HR.
    J Mol Cell Cardiol; 1987 Oct 25; 19(10):1025-36. PubMed ID: 2830402
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of the binding sites for the cardiotonic phosphodiesterase inhibitor [3H]LY186126 in ventricular myocardium.
    Artman M, Robertson DW, Mahony L, Thompson WJ.
    Mol Pharmacol; 1989 Aug 25; 36(2):302-11. PubMed ID: 2505059
    [Abstract] [Full Text] [Related]

  • 14. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 25; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 15. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium.
    Oquist NL, Strada SJ, Artman M.
    Pediatr Res; 1992 Mar 25; 31(3):300-4. PubMed ID: 1313959
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility.
    Weishaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR.
    Circ Res; 1987 Oct 25; 61(4):539-47. PubMed ID: 2820608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.